Nasus Pharma Ltd
Reverse DCF isn’t available yet
Not enough filings data to compute a starting per-share figure for NSRX (needs operating cash flow/capital expenditures, or diluted EPS as a fallback, for at least one recent quarter or fiscal year).
Reverse DCF isn’t available yet
Not enough filings data to compute a starting per-share figure for NSRX (needs operating cash flow/capital expenditures, or diluted EPS as a fallback, for at least one recent quarter or fiscal year).